Mark Plavsic

Mark Plavsic

Chief Tech/Sci/R&D Officer at AURA BIOSCIENCES, INC.

Net worth: 2 M $ as of 30/03/2024

63 year
Health Technology
Consumer Services
Commercial Services

Network origin in Mark Plavsic first degree

EntityEntity typeIndustry
Public Company Biotechnology 15
4
Holding Company Chemicals: Specialty 4
Public Company Biotechnology 3

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Mark Plavsic via their personal network

CompanySectorRelated peopleMain position
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Antony Mattessich

Director/Board Member

ELI LILLY AND COMPANY Pharmaceuticals: Major

Elisabet de los Pinos

Corporate Officer/Principal

Miscellaneous Commercial Services

Jean-Paul Mangeolle

Corporate Officer/Principal

North Carolina Specialty Hospital LLC

Cadmus Rich

Director/Board Member

Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

OCULAR THERAPEUTIX, INC. Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

Investment Managers

Karan Takhar

Portfolio Manager-Equities

Data Processing Services

Karan Takhar

Director/Board Member

Pharmaceuticals: Major

Karan Takhar

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Antony Mattessich

Yuan Xu

Janet Hopkins

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Antony Mattessich

Graduate Degree

Stanford University College/University

Daniel Shoemaker

David Michael

Doctorate Degree

Masters Business Admin

Imperial College London College/University

Giovanni Mariggi

Undergraduate Degree

Investment Managers

Giovanni Mariggi

Private Equity Analyst

Massachusetts Institute of Technology College/University

Karan Takhar

Undergraduate Degree

College/University

Cadmus Rich

Undergraduate Degree

Regis University College/University

Cadmus Rich

Masters Business Admin

University of California, Berkeley College/University

Antony Mattessich

Undergraduate Degree

University of California, Santa Barbara College/University

Daniel Shoemaker

Undergraduate Degree

Semiconductors

David Seldin

David Michael

Director/Board Member

Director/Board Member

University College London College/University

Giovanni Mariggi

Doctorate Degree

University of Barcelona College/University

Elisabet de los Pinos

Doctorate Degree

Instituto de Empresa SL College/University

Elisabet de los Pinos

Masters Business Admin

Miscellaneous Commercial Services

Daniel Shoemaker

Chief Tech/Sci/R&D Officer

Other Consumer Services

Elisabet de los Pinos

Corporate Officer/Principal

Pharmaceuticals: Major

Daniel Shoemaker

Corporate Officer/Principal

Miscellaneous Commercial Services

Cadmus Rich

Director/Board Member

ICX Biosystem

Daniel Shoemaker

Chief Tech/Sci/R&D Officer

Deaconess Medical Center

Elisabet de los Pinos

Corporate Officer/Principal

Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

Industrial Machinery

David Seldin

David Michael

Director/Board Member

Director/Board Member

Investment Managers

David Seldin

David Michael

Founder

Founder

Chemicals: Major Diversified

David Seldin

David Michael

Director/Board Member

Director/Board Member

Investment Managers

Giovanni Mariggi

Founder

Medical Specialties

Giovanni Mariggi

Director/Board Member

Miscellaneous Commercial Services

Giovanni Mariggi

Director/Board Member

Electrical Products

David Seldin

David Michael

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Giovanni Mariggi

Director/Board Member

Miscellaneous Commercial Services

Karan Takhar

David Johnson

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Cadmus Rich

Director/Board Member

Miscellaneous Commercial Services

David Seldin

David Michael

Director/Board Member

Director/Board Member

Biotechnology

Karan Takhar

Director/Board Member

Miscellaneous Commercial Services

Karan Takhar

Director/Board Member

ZENTALIS PHARMACEUTICALS, INC. Biotechnology

Karan Takhar

David Johnson

Director/Board Member

Chairman

Biotechnology

Giovanni Mariggi

Chairman

Miscellaneous Commercial Services

David Seldin

Director/Board Member

Investment Managers

Karan Takhar

Private Equity Investor

Statistics

International

United States 40
United Kingdom 6
Switzerland 4
Spain 3
Netherlands 2

Sectoral

Health Technology 16
Consumer Services 12
Commercial Services 11
Finance 7
Producer Manufacturing 3

Operational

Director/Board Member 127
Corporate Officer/Principal 29
Independent Dir/Board Member 26
Undergraduate Degree 17
Founder 12